Quest Plus Gel is a drug owned by ZOETIS INC. It is protected by 2 US drug patents filed from 2022 to 2026. Out of these, 1 patent is active and 1 patent has expired. Details of Quest Plus Gel’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6893652 | 25 Aug, 2022 | Expired |
Exclusivity Information
Quest Plus Gel holds 1 exclusivity out of which 1 has expired. Details of Quest Plus Gel's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Jul 30, 2018 |
About Quest Plus Gel
Quest Plus Gel is a drug
owned by ZOETIS INC.
Quest Plus Gel uses
Moxidectin, Praziquantel as the active
ingredients.
Active Ingredient:
Quest Plus Gel uses
Moxidectin,
Praziquantel
as the active ingredients.
Check out other Drugs and Companies using
Moxidectin, Praziquantel ingredient.